Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3
Francesco Beghini, Lauren J. McIver, Aitor Blanco‐Míguez, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 1347

Showing 1-25 of 1347 citing articles:

Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4
Aitor Blanco‐Míguez, Francesco Beghini, Fabio Cumbo, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 11, pp. 1633-1644
Open Access | Times Cited: 512
Bifidobacteria-mediated immune system imprinting early in life
Bethany M. Henrick, Lucie Rodriguez, Tadepally Lakshmikanth, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3884-3898.e11
Open Access | Times Cited: 501
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 315-324
Open Access | Times Cited: 391
METABOLIC: high-throughput profiling of microbial genomes for functional traits, metabolism, biogeochemistry, and community-scale functional networks
Zhichao Zhou, Patricia Q. Tran, Adam M. Breister, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 357
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 704-712
Open Access | Times Cited: 310
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation
Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2879-2898.e24
Open Access | Times Cited: 308
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews, Connie P.M. Duong, Vancheswaran Gopalakrishnan, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1432-1441
Open Access | Times Cited: 291
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 535-544
Open Access | Times Cited: 277
The person-to-person transmission landscape of the gut and oral microbiomes
Mireia Vallès-Colomer, Aitor Blanco‐Míguez, Paolo Manghi, et al.
Nature (2023) Vol. 614, Iss. 7946, pp. 125-135
Open Access | Times Cited: 242
Critical Assessment of Metagenome Interpretation: the second round of challenges
Fernando Meyer, Adrian Fritz, Zhi-Luo Deng, et al.
Nature Methods (2022) Vol. 19, Iss. 4, pp. 429-440
Open Access | Times Cited: 240
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
Joseph Tintelnot, Yang Xu, Till Robin Lesker, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 168-174
Open Access | Times Cited: 231
Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain
Aimée Parker, Stefano Romano, Rebecca Ansorge, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 212
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Gianluca Ianiro, Michal Punčochář, Nicolai Karcher, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1913-1923
Open Access | Times Cited: 183
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Zachary D. Wallen, Ayşe Demirkan, Guy Twa, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 182
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
Aura Ferreiro, JooHee Choi, Jian Ryou, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 700
Open Access | Times Cited: 151
A review of computational tools for generating metagenome-assembled genomes from metagenomic sequencing data
Chao Yang, Debajyoti Chowdhury, Zhenmiao Zhang, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 6301-6314
Open Access | Times Cited: 147
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 147
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease
Jonathan Lee, Damian R. Plichta, Larson Hogstrom, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 8, pp. 1294-1304.e4
Open Access | Times Cited: 143
Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance
Francesca De Filippis, Lorella Paparo, Rita Nocerino, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 140
Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID
John P. Haran, Evan S. Bradley, Abigail L. Zeamer, et al.
JCI Insight (2021) Vol. 6, Iss. 20
Open Access | Times Cited: 129
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
Safae Terrisse, Lisa Derosa, Valerio Iebba, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 9, pp. 2778-2796
Open Access | Times Cited: 118
Ultra-deep sequencing of Hadza hunter-gatherers recovers vanishing gut microbes
Matthew M. Carter, Matthew R. Olm, Bryan D. Merrill, et al.
Cell (2023) Vol. 186, Iss. 14, pp. 3111-3124.e13
Open Access | Times Cited: 113
Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly
Nicolai Karcher, Eleonora Nigro, Michal Punčochář, et al.
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Serena Porcari, Nicolas Benech, Mireia Vallès-Colomer, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 712-733
Open Access | Times Cited: 110
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 906-916
Open Access | Times Cited: 109
Page 1 - Next Page

Scroll to top